首页> 外文期刊>Universal Journal of Public Health >Risk Factors for Multi-drug Resistant Tuberculosis in Addis Ababa, Ethiopia
【24h】

Risk Factors for Multi-drug Resistant Tuberculosis in Addis Ababa, Ethiopia

机译:埃塞俄比亚亚的斯亚贝巴的多药耐药结核病危险因素

获取原文
获取外文期刊封面目录资料

摘要

Multi-Drug resistant Tuberculosis (MDR-TB) is becoming a major challenge of the tuberculosis (TB) control program in Ethiopia. The objective of the study was to investigate risk factors for MDR-TB in Addis Ababa. Comparative cross-sectional study was conducted to determine the risk factors for MDR-TB in Addis Ababa. MDR and non MDR-TB cases were compared on key socio-demographic and patient related clinical features for multidrug-resistance. A total 439 (113 MDR-TB and 326 non MDR-TB) were enrolled in to the study. Standard data abstraction instrument were used. Data were entered and analysed using SPSS version 18 for windows. Initial descriptive analyses of all variables of interest, odds ratio, univariate and subsequent multiple regression analysis was carried out. Male sex (OR 2, 95%CI 1.4-5), younger age of 15-34 years (OR 2.8, 95%CI 1.7–6.4), twice or more episodes of TB treatment (OR 14, 95%CI 1.3-9), treatment category of failure after re-treatment (OR 4, 95%CI 2.5-6.83), pulmonary TB (OR 2, 95%CI 1.7-5) and TB/HIV co-infection (OR 2.66, 95%CI 1.32-5.6) were associated with the risks of becoming ill with MDR-TB. The national TB prevention and control programme should be given priority for routine Line Probe Assay to make early diagnosis of MDR-TB particularly among those identified risk groups.
机译:耐多药结核病(MDR-TB)成为埃塞俄比亚结核病(TB)控制计划的主要挑战。该研究的目的是调查亚的斯亚贝巴耐多药结核病的危险因素。进行了比较横断面研究,以确定亚的斯亚贝巴耐多药结核病的危险因素。比较了耐多药和非耐多药结核病例的主要社会人口学特征和患者相关的多药耐药临床特征。该研究共纳入439人(113个耐多药结核病和326个非耐多药结核病)。使用标准数据抽象工具。使用Windows的SPSS版本18输入和分析数据。对所有关注变量,比值比,单变量和随后的多元回归分析进行了初始描述性分析。男性(OR 2,95%CI 1.4-5),15-34岁以下的年轻人(OR 2.8、95%CI 1.7–6.4),两次或两次以上的结核病治疗(OR 14,95%CI 1.3-9) ),再治疗后失败的治疗类别(OR 4,95%CI 2.5-6.83),肺结核(OR 2,95%CI 1.7-5)和TB / HIV合并感染(OR 2.66,95%CI 1.32 -5.6)与罹患耐多药结核病的风险有关。例行线探针检测应优先考虑国家结核病预防和控制计划,以早期诊断耐多药结核病,尤其是在那些已确定的风险人群中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号